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ABSTRACT Citronellal (CT) is a monoterpenoid and the major constituent of the mixture of terpenoids that give the
citronella oil its lemon scent. Citronella oil is widely used around the world for various purposes and is mainly obtained from
plants of the Cymbopogon genus, which are known as ‘‘lemongrass.’’ Considering these plants have been used worldwide for
various medicinal purposes, the interest of researchers to understand the biological activities of monoterpenoids related to the
Cymbopogon genus has been increasing. In the present work, we investigated the antinociceptive action and the redox
properties of CT. Our results indicate that intraperitoneal injection of CT was effective in reducing nociceptive face-rubbing
behavior in both phases of the formalin test, which was also naloxone-sensitive. CT also evoked antinociceptive response in
the capsaicin and glutamate tests. The total radical-trapping antioxidant parameter and total antioxidant reactivity assays
indicate that CT at doses of 0.1 and 1 mg=mL exerts a significant antioxidant activity, which is probably related to its ability to
scavenge superoxide and nitric oxide, but not H2O2 or hydroxyl radicals, as evaluated separately by specific in vitro tests.
These results show for the first time the antinociceptive potential of CT and indicate that the antioxidant properties of this
compound may rely on its mechanism of biological actions because CT-containing natural products are used to treat various
diseases related to oxidative stress and reactive species.
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INTRODUCTION
Epidemiological studies have been suggested an in-verse correlation between the consumption of certain
natural products and the risk of degenerative diseases, can-
cer, cardiovascular diseases, and chronic pain.1–4 The pres-
ence of secondary metabolites with antioxidant activity or
other redox-related properties is generally associated with
such properties, as many of the conditions in which these
natural products have been observed to exert a preven-
tive=therapeutic action are strongly related to oxidative
stress and increased reactive species production.5,6 The in-
crease in reactive species production may result from mul-
tiple endogenous (i.e., aging, mitochondrial metabolism)
and exogenous (smoke, ultraviolet radiation, pollution)
factors and induce oxidative damage to biomolecules such as
DNA, proteins, and lipids.
The essential oils are natural products that exhibit vari-
ous biological properties, such as analgesic,7 anticonvul-
sant,8 and anxiolytic9 effects. Those effects are attributed to
the monoterpenes, which are the major chemical compo-
nents of these essential oils. Citronellal (CT) is a monoter-
pene product from plant secondary metabolism. It is
typically isolated as a non-racemic mixture of its R and S
enantiomers by steam distillation or solvent extraction from
the oils of Corymbia citriodora Hill and Johnson (former
Eucalyptus citriodora Hook), Cymbopogon nardus, Cym-
bopogon citratus, and Cymbopogon winterianus (‘‘Java
citronella’’).8,10 It is also found in more than 50 other es-
sential oils. Plants from the Cymbopogon genus are known
under various names, the most popular being ‘‘lemongrass’’
and ‘‘citronella.’’11 Cymbopogon leaves are used as infusion
preparations for use as spices, medicinal and recreational
teas, soups, and curries.11 Other CT-containing plants, such
as members of the genuses Eucalyptus, Melissa, Mentha,
Allium, and Cinnamomum, among others, also present no-
table nutritional value and are important food=spice sources
in different parts of the world.12 In Cymbopogon (lemongrass)
and Melissa officinalis (balm), CT is considered a major
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constituent of the leaves, contributing to a great extent of the
aromatic scent of these plants. The use of lemongrass in
curries in Asia and in spices in Africa is also related to
prevention of food spoilage, and the preservative properties
of these plants are probably related to their high content of
essential oils.13–16 Nonetheless, isolated properties of the
different essential oil components of these medicinal plants,
such as CT, have been poorly studied.
CT is produced by many plants traditionally used to treat
different conditions by widespread populations around the
world, such as South America and Asia.17–19 Although CT
has been identified, purified, and chemically well defined, its
biological and antioxidant properties have been very poorly
explored. For instance, plants of the Cymbopogon genus,
which are rich in mono-, di-, and triterpenes, are widely used
to treat different forms of pain.20–24 Holanda Pinto et al.25
demonstrated the analgesic effect of the triterpenoid a,b-
amyrin, a compound closely related to CT. Also, CT and
related monoterpenoids were reported to inhibit cytochrome
P-450 CYP2B1 and other dehydrogenases,26 indicating that
such compounds may exert a diverse array of biological
actions.
Pain is a complex, multidimensional experience espe-
cially relevant to the orofacial region because the face and
mouth have a particular biological and psychological
meaning for each individual. Many of the most common
types of pain occur in the orofacial region, and most diffi-
culties in the management of conditions related to acute and
chronic orofacial pain arise from a lack of understanding of
its mechanisms.27 Free radicals, especially nitric oxide
(NO), are also involved in the control of processes related to
pain because such species evoke cell signaling cascades
related to modulation of neuropathic and inflammatory
pain.28 In the present work, we investigated the anti-
nociceptive effect of CT and its redox properties.
MATERIALS AND METHODS
Animals
Male Swiss mice (weighing 30–36 g) and male Wistar
rats (weighing 230–260 g), 2–3 months of age, were used
throughout this study. The animals were randomly housed in
appropriate cages at 22 28C on a 12-hour light=dark cycle
(lights on 6:00 a.m. to 6:00 p.m.) with free access to food
and water. All experiments were carried out between 9:00
a.m. and 2:00 p.m. in a quiet room. Experimental protocols
were approved by the Animal Care and Use Committee
(CEPA=UFS number 12=08) at the Federal University of
Sergipe, Aracaju, Brazil.
Chemicals
2,2¢-Azobis(2-methylpropionamidine) dihydrochloride
(AAPH), luminol (5-amino-2,3-dihydro-1,4-phthalazine-
dione), 2-deoxyribose, glycine (aminoacetic acid), Griess
reagent, sodium nitroprusside (SNP), ascorbic acid, 2-
thiobarbituric acid (TBA) (4,6-dihydroxypyrimidine-2-
thiol), hydrogen peroxide, adrenaline, catalase, and
superoxide dismutase (SOD) were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). Trolox (6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid) was pur-
chased from Aldrich Chemical Co. (Milwaukee, WI, USA).
Water was purified using a Milli-Q system from Millipore
(Milford, MA, USA). All other reagents used in this study
were of highest analytical or high-performance liquid
chromatography grade. For all in vivo experiments the fol-
lowing agents were used: CT [(RS)-()-CT, 98% purity,
Dierberger, Barra Bonito, Brazil], morphine hydrochloride
(Unia˜o Quı´mica, Sa˜o Paulo, Brazil), naloxone hydrochlo-
ride (Neoquı´mica, Anapolis, Brazil), 37% formaldehyde
(Vetec, Rio de Janeiro, Brazil), Tween 80 (polyoxyethylene-
sorbitan monolate), and capsaicin (Sigma). Vehicle for an-
imals was 1 drop of Tween 80 (0.2%) dissolved in 0.9%
NaCl solution. In those protocols the agents were injected
intraperitoneally at a dose volume of 1 mL=10 g. The
physiologic solution used for in vivo tests was composed of
150 mM NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2,
10 mM glucose, and 10 mM HEPES, adjusted to pH 7.4 with
NaOH.
Formalin test
Orofacial nociception was induced in mice by subcuta-
neous injection of 20mL of 2% formalin into the right upper
lip (perinasal area), using a 27-gauge needle.27,29 This vol-
ume and percentage concentration of formalin were selected
from our pilot studies that showed a pain-related biphasic
behavioral response (face-rubbing) of great intensity at
periods of 0–5 minutes (first phase) and 15–40 minutes
(second phase). Pain was quantified at those periods by
measuring the time (in seconds) that the animals spent face-
rubbing in the injected area with their fore- or hindpaws.27
To assess the effects of test drugs, groups of rats (n¼ 8 per
group) were pretreated systemically with vehicle (1 drop of
Tween 80 [0.2%] in distilled water, the solvent for CT) or CT
(50, 100, and 200 mg=kg, i.p.), 0.5 hours before the local
injection of formalin. Morphine (3 mg=kg, i.p.), administered
30 minutes before the algogen, was included as the positive
control. In separate experiments, the possible involvement of
opioid mechanism was assessed in the antinociception pro-
duced by CT or morphine with naloxone (1.5 mg=kg, i.p.), an
opioid antagonist, injected simultaneously.
Capsaicin test
The orofacial pain was induced by capsaicin administra-
tion. Mice (n¼ 8) were injected with capsaicin (20mL,
2.5mg) subcutaneously into the right upper lip (perinasal
area), using a 27-gauge needle. Capsaicin was dissolved in
ethanol, dimethyl sulfoxide, and distilled water (1:1:8 by
volume). In pilot studies, rodents manifested pain-related
face-rubbing behavior following the injection of capsaicin
with a high intensity for a 10–20-minute period. Therefore,
pain quantification was performed at this period measuring
the time (in seconds) that the animals spent face-rubbing the
injected area with their fore- or hindpaws. CT (50, 100, and
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200 mg=kg, i.p.) or vehicle (1 drop of Tween 80 [0.2%] in
distilled water, the solvent for CT) was given to animals as
described for the formalin test, 2 hours before the local in-
jection of capsaicin. Morphine (5 mg=kg, i.p.), administered
30 minutes before the algogen, was included as the positive
control.
Glutamate-induced nociception
In an attempt to provide more direct evidence concerning
the interaction of the CT with the glutamatergic system, we
separately investigated whether or not the CT was able to
antagonize glutamate-induced orofacial nociception in
mice. The procedure used was similar to that previously
described by Beirith et al.,30 with some alterations. A vol-
ume of 20mL of glutamate (25 mM per paw prepared in
phosphate-buffered saline) was injected in the right upper
lip (perinasal area), using a 27-gauge needle. Animals were
observed individually for 15 minutes following glutamate
injection. Pain quantification was performed at this period
measuring the time (in seconds) that the animals spent face-
rubbing the injected area with their fore- or hindpaws. An-
imals (n¼ 8 per group) were treated with CT (50, 100, and
200 mg=kg, i.p.) or vehicle (1 drop of Tween 80 [0.2%] in
distilled water, the solvent for CT) 30 minutes before glu-
tamate injection.
Leukocyte migration to the peritoneal cavity
The leukocyte migration was induced by injection of
carrageenan (500 mg per cavity, i.p., 500 mL) into the peri-
toneal cavity of rats 1 hour after administration of CT (50,
100, and 200 mg=kg, i.p.), vehicle (1 drop of Tween 80
[0.2%] in distilled water, the solvent for CT), or dexa-
methasone (2 mg=kg, s.c.) by modification of the technique
previously described by Bastos et al.31 Mice (n¼ 6 per
group) were euthanized by cervical dislocation 4 hours after
carrageenan injection. Shortly after, phosphate-buffered
saline containing EDTA (1 mM, i.p., 10 mL) was injected.
Immediately a brief massage was done for further fluid
collection, which was centrifuged (750 g for 5 minutes) at
room temperature. The supernatant was disposed of, and
1 mL of phosphate-buffered saline was added to the pre-
cipitate. An aliquot of 10mL from this suspension was dis-
solved in 200mL of Turk’s solution, and the total cells were
counted in a Neubauer chamber, under optic microscopy.
The results were expressed as the number of neutro-
phils=mL. The percentage of the leukocyte inhibition was
calculated as (1 T=C)100, where T represents the treated
group’s leukocyte counts and C represents the control
group’s leukocyte counts.
Motor activity evaluation
To investigate if the treatments could influence the motor
activity of the animals and consequently impair the assess-
ment of the nociceptive behavior in experimental models,
the motor activity was evaluated in a Rota-rod appara-
tus.32,33 Initially, the mice able to remain on the Rota-rod
apparatus (AVS, Sa˜o Paulo) longer than 120 seconds
(9 rpm) were selected 24 hours before the test.34 Then the
selected animals were divided into five groups (n¼ 8 per
group) and treated intraperitoneally with vehicle (1 drop of
Tween 80 [0.2%] in distilled water, the solvent for CT), CT
(25, 50 and 100 mL=kg, i.p.), or diazepam (3 mg=kg). Thirty
minutes later, each animal was tested on the Rota-rod ap-
paratus, and the time (in seconds) it remained on the bar for
up to 120 seconds was recorded after 30, 60, and 90 minutes.
Total radical-trapping antioxidant parameter
An adapted method of total radical-trapping antioxidant
parameter (TRAP) assay was used to determine the capacity
of CT to trap a flow of water-soluble peroxyl radical pro-
duced at constant rate, through thermal decomposition of
AAPH.35 In brief, the reaction mixture containing 4 mL of
the free radical source (10 mM AAPH) in 0.1 M glycine
buffer (pH 8.6), 10 mL of the test samples at different
concentrations, and 10 mL of luminol (4 mM) as the external
probe to monitor radical production was incubated at 258C.
Trolox (a water-soluble vitamin E analog) was used as
reference peroxyl radical scavenger molecule. The chemi-
luminescence produced was directly proportional to the
radical generation and measured in out-of-coincidence
mode (Wallac 1409 DSA liquid scintillation counter, Wallac
Oy, Turku, Finland) as counts per minute. The TRAP of CT
was evaluated for instantaneously inhibition of chemilumi-
nescence as the area under curve (AUC). The total antiox-
idant reactivity (TAR) was calculated as the ratio of light
intensity in absence of samples (I0)= light intensity right
after CT addition (I) and expressed as a percentage of in-
hibition. CT vehicle was 1% dimethyl sulfoxide. AUC and
radical basal production were acquired by software
(GraphPad Software Inc., San Diego, CA, USA) analysis
of data.
TBA-reactive substances assay
TBA-reactive species (TBARS) assay was used for
quantify lipid peroxidation,36 and an adapted TBARS
method was used to measure the antioxidant capacity of CT
using egg yolk homogenate as the lipid-rich substrate.35 In
brief, egg yolk was homogenized (1% wt=vol) in 20 mM
phosphate buffer (pH 7.4), and 1 mL of homogenate was
sonicated and then homogenized with 0.1 mL of CT at dif-
ferent concentrations or controls in different concentrations
prepared immediately before use. Lipid peroxidation was
induced by addition of 0.1 mL of AAPH solution (0.12 M).
Trolox was used as the reference antioxidant molecule
(positive control); the negative control was only CT vehicle
(1% dimethyl sulfoxide). Reactions were carried out for 30
minutes at 378C. After cooling, samples (0.5 mL) were
centrifuged with 0.5 mL of trichloroacetic acid (15%) at
1,200 g for 10 minutes. A 0.5-mL aliquot from supernatant
was mixed with 0.5 mL of TBA (0.67%) and heated at 958C
for 30 minutes. After cooling, samples absorbance was
measure using a spectrophotometer at 532 nm. The results
were expressed as percentage of TBARS formed by AAPH
alone (induced control).
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Scavenging activity of NO
NO was generated from spontaneous decomposition of
SNP in 20 mM phosphate buffer (pH 7.4). Once generated,
NO interacts with oxygen to produce nitrite ions, which
were measured by the Griess reaction.37 The reaction mix-
tures (1 mL each) containing 10 mM SNP in phosphate
buffer and vehicle (1% dimethyl sulfoxide) or CT at dif-
ferent concentrations were incubated at 378C for 1 hour. A
0.5-mL aliquot was taken and homogenized with 0.5 mL of
Griess reagent. The absorbance of chromophore was mea-
sured at 540 nm. Percentage inhibition of NO generated was
measured by comparing the absorbance values of negative
controls (only 10 mM SNP and vehicle) and assay prepara-
tions. Results were expressed as percentage of nitrite formed
by SNP alone.
Hydroxyl scavenging activity
The formation of OH (hydroxyl radical) from the Fenton
reaction was quantified using 2-deoxyribose oxidative deg-
radation.38 The principle of the assay is the quantification of
the 2-deoxyribose degradation product, malondialdehyde,
by its condensation with TBA. In brief, typical reactions
were started by the addition of Fe2þ (6 mM final concen-
tration) to solutions containing 5 mM 2-deoxyribose,
100 mM H2O2, and 20 mM phosphate buffer (pH 7.2). To
measure CT antioxidant activity against hydroxyl radical,
different concentrations of CT and vehicle (1% dimethyl
sulfoxide) were added to the system before Fe2þ addition.
Reactions were carried out for 15 minutes at room temper-
ature and were stopped by addition of 4% (vol=vol) phos-
phoric acid followed by 1% (wt=vol) TBA (in 50 mM
NaOH). Solutions were boiled for 15 minutes at 958C and
then cooled at room temperature. The absorbance was
measured at 532 nm, and results were expressed as mal-
ondialdehyde equivalents formed by Fe2þ and H2O2.
Catalase-like activity
The ability of CT to scavenge H2O2 (‘‘catalase-like ac-
tivity’’) was measured as described previously.39 In brief,
H2O2 diluted in 0.02 M phosphate buffer (pH 7.0) to obtain a
5 mM final concentration was added to microplate wells in
which different concentrations was placed. The microplate
was immediately placed to monitor the rate of H2O2 de-
composition in the microplate reader set at 240 nm. Di-
methyl sulfoxide at 1% was used as the vehicle.
SOD-like activity
The ability of CT to scavenge superoxide anion (‘‘SOD-
like activity’’) was measured as previously described.40
CT was mixed with native purified catalase (100 U=mL
stock solution) in glycine buffer (50 mM, pH 10.2). CT
vehicle was 1% dimethyl sulfoxide. Superoxide genera-
tion was initiated by addition of 2 mM adrenaline, and
adrenochrome formation was monitored at 480 nm for
5 minutes at 328C. Superoxide production was determined
by monitoring the reaction curves of samples and measured
as a percentage of the rate of adrenaline autooxidation into
adrenochrome.
Statistical analysis
Data obtained were evaluated by one-way analysis of
variance followed by Dunnett’s test. Differences were
considered to be statistically significant when P< .05. Data
were analyzed with GraphPad Prism version 5.01 software
(1992–2007, GraphPad Software Inc.).
RESULTS
The TRAP and TAR assays indicate that CT presents a
significant antioxidant activity at the highest doses tested. At
100mg=mL and 1 mg=mL, CT inhibited the pro-oxidant
pulse generated by the free radical-producing system at the
TRAP assay, and TAR calculation indicates a significant
antioxidant potential at 1 mg=mL (Fig. 1A and B). On the
other hand, all doses of CT were not able to prevent lipo-
peroxidation induced by AAPH in vitro in a lipid-enriched
system (Fig. 1C).
To establish the profile of CT antioxidant activity, we
tested the scavenger activity of CT against different reactive
species. CT was able to significantly inhibit superoxide
radical production at the doses of 100mg=mL and 1 mg=mL,
as assessed by the SOD-like activity assay (Fig. 2A).
However, at these same doses, CT inhibited spontaneous
degradation of H2O2, as determined by the catalase-like
activity assay (Fig. 2B). CT also demonstrated inhibition of
SNP-induced nitrite production, indicating a scavenging
activity of CT toward NO (Fig. 2C). On the other hand, no
activity against hydroxyl radicals was observed in the 2-
deoxyribose degradation assay (Fig. 2D). Altogether, these
results suggest that the mechanism of CT antioxidant effects
observed in TRAP and TAR assays relies on its ability to
scavenge NO, superoxide, and H2O2 molecules, but not
hydroxyl radicals.
Intraperitoneal administration of CT to mice produced a
dose-dependent reduction in formalin-induced face-rubbing
behavior (Fig. 3A). Antinociception in both the first and
second phases was significantly enhanced. We tested the
effect of morphine, which reduced the nociceptive behavior
in both phases as well, to compare with the effect of CT and
evaluate the involvement of the opioid system in the effect
of CT. The effects of both CT and morphine were inhibited
by naloxone, a specific antagonist of morphinomimetic re-
ceptors.
CT significantly (P< .001) reduced, in a dose-dependent
manner, the face-rubbing behavior induced by administration
of capsaicin to mice (Fig. 3B). All doses produced an effect
similar to that of morphine (3 mg=kg). Also, at doses of 100
and 200 mg=kg, i.p., CT significantly decreased the face-
rubbing behavior induced by glutamate (Fig. 4A). In the
Rota-rod test, CT-treated mice did not show any significant
motor performance alterations, indicating the results shown
here are not due to inhibition of motor activity (Fig. 4B).
Carrageenan (500mg per cavity) induced leukocyte mi-
gration to the peritoneal cavity 4 hours after stimulus. Figure 5
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shows the inhibitory effect of CT on carrageenan-induced
responses in higher doses (45.9% and 65.7% at doses of 100
and 200 mg=kg, respectively). The results obtained with the
control group support the effect of CT because the vehicle
presented no activity, and the positive control drug, dexa-
methasone (2 mg=kg, s.c.), inhibited (92.2%, P< .001) the
carrageenan-induced leukocyte migration to the peritoneal
cavity.
DISCUSSION
CT is a monoterpenoid and the major constituent of the
mixture of terpenoids that give the citronella oil its lemon
scent.12 Citronella oil is widely used around the world
for various purposes and is mainly obtained from plants
of the genus Cymbopogon, which are collectively known as
‘‘lemongrass.’’41,42 Such plants are used in teas, soups, and
curries in Asia and are also suitable for poultry, fish, and
seafood. Lemongrass is a tall perennial grass, and the lower
part of the stem is used as a component of different curry
dishes in Asia. Ground pastes of lemongrass are also a
common component of curry powders.43 In Thailand, lem-
ongrass is also used to make a refreshing cold drink called
‘‘Nam Takrai,’’ while in Brazil infusions containing lem-
ongrass are commonly used in folk medicine as a regulator
of the functions of digestive and circulatory systems.44 CT
and related compounds are also major constituents in M.
officinalis (‘‘balm,’’ ‘‘lemon-balm,’’ ‘‘Cidreira’’), which is
extensively used as tea for both medicinal and recreational
purposes and as a flavoring agent in Brazil, England, and
Southern Europe. Citronella oil is used in food, in soaps, as
an antiseptic, and also as an insect repellent.14,45 Recently, a
species of lemongrass (C. citratus) was observed to selec-
tively induce apoptosis in malignant cancer cells, and
this property was attributed to citral.46 This has led to an
increase in the interest of researchers to explore the bio-
logical activities of monoterpenoids related to the Cymbo-
pogon genus, considering these plants have been used for
various medicinal and other purposes. Nonetheless, there are
very few works concerning the effects of CT for internal use.
FIG. 1. Antioxidant activity and prevention of lipoperoxidation
in vitro by citronellal. (A) Total radical-trapping antioxidant param-
eter (TRAP) of citronellal at different concentrations. Bars represent
the area under the curve (arbitrary units) generated by 2,20-azobis(2-
methylpropionamidine) dihydrochloride (AAPH), a free radical
source, in the presence of different concentrations of citronellal, as
described in Materials and Methods. The system is the area generated
during reading of luminescence by AAPH alone. *P< .05,
**P< .001 by one-way analysis of variance with Duncan’s post hoc
analysis. (B) Total antioxidant reactivity (TAR) was calculated as the
ratio of light intensity in the absence of samples and the light in-
tensity right after citronellal addition and expressed as a percentage of
inhibition (I0=I) using the same raw data. *P< .05 byone-way anal-
ysis of variance with Duncan’s post hoc analysis. (C) Thiobarbituric
acid-reactive substances (TBARS) in vitro. Lipid extracted from egg
yolk was subjected to oxidative damage by incubation with AAPH,
and the ability of different concentrations of citronellal to prevent
TBARS formation was analyzed. Control means basal lipid perox-
idation; the AAPH-alone group is considered 100% of oxidative
damage. *P< .05 relative to the control group by one-way analysis of
variance with Duncan’s post hoc analysis. Data in all experiments
represent mean SEM values (n¼ 5) from experiments performed in
triplicate.
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It was observed that isolated CT or CT-enriched essential
oils=plant extracts inhibited P-glycoprotein-mediated
transport in breast cancer cells,47 exhibited anticonvulsant
activity, and inhibited acetyl- and butyrylcholinesterases.48
However, there are no studies on the redox properties of CT.
Considering the involvement of free radicals and related
species in the molecular mechanisms underlying the path-
ogenesis and progression of different forms of diseases, such
as cancer and neurodegenerative conditions, the study of the
redox-related properties of CT may help to understand the
mechanisms of its action and its efficacy to treat such con-
ditions. Considering also the wide use of CT-containing
plants and extracts in popular medicine to treat diseases
related to chronic and acute forms of pain, we found inter-
esting to evaluate its antinociceptive effect in an animal
model.
Acute administration of CT on formalin-induced or-
ofacial pain caused pronounced antinociception, suggest-
ing a central analgesic effect. The antagonistic effect of
naloxone suggests participation of the opioid system in
the modulation of pain by CT. Also, the inhibitory effect
observed with CT on capsaicin- and in the second phase
of formalin-induced face-rubbing behavior may be a result
of substance P release inhibition or a direct blocking
action on its receptor, neurokinin-1 (NK-1), by CT.25 In
this regard, a previous study provided evidence for tonic
FIG. 2. In vitro characterization of citronellal antioxidant activity. (A) Superoxide dismutase-like activity. Control means spontaneous su-
peroxide degradation. (B) Catalase-like activity. Control means spontaneous H2O2 degradation. (C) Nitric oxide scavenging activity. SNP means
nitrite formation induced by sodium nitroprusside alone, considered as 100% of nitric oxide formation. (D) Hydroxyl radical formation. Control is
2-deeoxyribose degradation to malondialdehyde (MDA) induced by hydroxyl radicals generated by H2O2 and iron, considered 100% of hydroxyl
radical formation in this system. Data are mean SEM values (n¼ 5) from experiments performed in triplicate. *P< .05 in relation to control,
**P< .05 in relation to *groups by one-way analysis of variance with Duncan’s post hoc analysis.
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activation of NK-1 receptors, through administration of
the NK-1 receptor antagonist SR14033, which blocked
the second phase of the orofacial formalin test response
in rats.49,50 Additionally, our results also show that CT
inhibited the nociceptive response caused by right vibrissa
pad injection of glutamate into mice. This nociceptive
response caused by glutamate seems to involve peripheral,
spinal, and supraspinal sites, and its action is mediated
by N-methyl-d-aspartate and non–N-methyl-d-aspartate
receptors.30 Several studies have demonstrated that those
excitatory amino acid receptors are involved in nocicep-
tive primary afferent transmission, in both the develop-
ment and maintenance of painful response.51 Thus, the
suppression of glutamate-induced nociception by CT
treatment may be associated with its interaction with the
glutamatergic system.
The results presented here indicate that CT exhibits a
significant antioxidant activity, as seen in TRAP=TAR as-
says, which are widely accepted methods to reliably estab-
lish the ability of isolated molecules to act as general
antioxidants in vitro. Also, we demonstrated that CT is able
to scavenge NO and superoxide molecules. These are rele-
vant species to the development of oxidative and nitrosative
stress, which in turn trigger diverse deleterious processes in
cells. Antioxidant activities by natural products are gener-
ally thought to be responsible for the health-promoting ef-
fects observed in diets and supplementations using
vegetables and other plant-derived products. Prevention of
cardiac diseases, cancer, and neurodegenerative conditions
observed in epidemiologic studies is ascribed to the pres-
ence of secondary metabolites in such diets and=or supple-
mentations. Our results also have shown that CT had no
FIG. 3. Effect of citronellal (CT) on formalin-induced orofacial
pain-related face-rubbing response in mice. Drugs were administered
0.5 hour before formalin injection into the right upper lip (perinasal
area): (A) first phase (0–5 minutes) and (B) second phase (15–40
minutes). The effects of morphine (MOR) and=or naloxone (NAL)
pretreatments on the antinociceptive effects of CT (200 mg=kg, i.p.)
were examined. MOR or NAL was injected 0.5 hour before formalin.
Data are mean SEM values from eight animals. *P< .001 com-
pared with control by analysis of variance followed by Dunnett’s test.
FIG. 4. Effect of CT on capsaicin-induced orofacial pain-related
face-rubbing response in mice. (A) Vehicle, CT, or MOR was ad-
ministered 0.5 hour before capsaicin injection into the right upper lip
(perinasal area). Data are mean SEM values from eight animals.
*P< .05, **P< .001 compared with control by analysis of variance
followed by Dunnett’s test. (B) Time (in seconds) on the Rota-rod
observed in mice after intraperitoneal treatment with vehicle (con-
trol), CT (50, 100, or 200 mg=kg), or diazepam (DZP) (1.5 mg=kg).
The motor response was recorded for the following 120 seconds after
drug treatment. Data are mean SEM values (n¼ 10). Statistical
significance of differences versus the control group was calculated
using analysis of variance followed by Dunnett’s test: *P< .001.
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preventive action on free radical-induced lipid oxidation
when incubated in a lipid-rich system, as seen in the TBARS
assay (Fig. 1C). This result suggests that CT is not able to act
directly as an antioxidant agent by directly interacting with
lipids, which is the case of other lipophilic antioxidants such
as a-tocopherol. It is possible that lipid peroxidation to cell
membranes in vivo may be prevented in the presence of CT,
especially in stress conditions related to increased peroxyl
and NO radicals. CT antioxidant action against these species
may lower cellular oxidative stress levels and consequently
diminish the attack of free radicals on lipid membranes,
protecting these lipids against oxidation by an indirect
mechanism.
We also found that CT presented a pronounced anti-
nociceptive effect in all tests, and the results from the Rota-
rod test demonstrated that CT did not influence motor
activity, which could impair the assessment of the nociceptive
behavior. It is possible that such a antinociceptive effect of
CT is at least in part mediated by its antioxidant actions
because reactive species may play a relevant role in pro-
inflammatory processes.52 During acute and chronic inflam-
mations, superoxide is produced at rates that overwhelm
the capacity of the endogenous SOD enzymes to remove it,
resulting in superoxide-mediated injury.52 Important pro-
inflammatory roles for superoxide include endothelial cell
damage and increased microvascular permeability,52 up-
regulation of adhesion molecules such as intercellular adhe-
sion molecule-1 and P-selectin that recruit neutrophils to sites
of inflammation, lipid peroxidation, and oxidation, and DNA
damage. Superoxide also activates redox-sensitive transcrip-
tion factors including nuclear factor-kB and activator protein-1,
which in turn regulate genes encoding various pro-inflammatory
and pro-nociceptive cytokines.52
NO is a key anti-inflammatory and cytoprotective agent
when acting as a signaling molecule. We observed that CT
is able to inhibit NO production by SNP in vitro, which
could indicate that NO quenching by CT would enhance
inflammation and nociception. However, it is important to
point out that the interaction of NO with other reactive
species results in a general loss of its ‘‘beneficial’’ effects;
for instance, NO-mediated activation of cyclooxygenase
and subsequent release of beneficial and anti-inflammatory
prostaglandins is lost when superoxide production is also
enhanced because interaction between superoxide and NO
leads to in situ formation of peroxynitrite,53 a potent cy-
totoxic and pro-inflammatory reactive species. Thus,
blockade of peroxynitrite formation by preventing NO or
superoxide excessive formation and=or removal of perox-
ynitrite also results in cytoprotective and anti-inflamma-
tory effects.
Cell recruitment during inflammation depends on the
orchestrated release of local mediators that are responsible
for local vascular and tissue changes as well as for the re-
cruitment of host defense cells.54 The inflammation induced
by carrageenan involves cell migration, plasma exudation,
and production of mediators, such as nitric oxide, prosta-
glandin E2, interleukin-1b, interleukin-6, and tumor necrosis
factor-a.55,56 Those mediators are able to recruit leukocytes,
such as neutrophils, in several experimental models. A pu-
tative mechanism associated with this activity may be in-
hibition of the synthesis of many inflammatory mediators
whose involvement in the cell migration is well established.
However, the exposure to inflammatory mediators such
as carrageenan, cytokines, and endotoxin leads to the in-
duction of both cyclooxygenase and NO synthase (inducible
NO synthase or type 2 NO synthase).57 This observation
is also supported by several studies showing that the anti-
inflammatory activities of natural products, as monoter-
penes (linalool and geranial), were a result of inhibiting
NO production in carrageenan-induced inflammation on
rodents.58,59 The experiments with carrageenan clearly
showed that CT (100 and 200 mg=kg, i.p.) inhibits leukocyte
mobilization to the peritoneal cavity.
In conclusion, we showed here evidence for the first time
that CT has antioxidant properties and modulates neuro-
pathic and inflammatory pain in the test models of orofacial
pain induced by formalin (through a naloxone-sensitive
mechanism), capsaicin, and glutamate. The antioxidant
properties of CT may be involved in the mechanism of its
antinociceptive action and also possibly in other biological
actions of CT. Nonetheless, future studies should address
redox properties and their involvement in the mechanism of
CT action in biological systems.
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FIG. 5. Effect of CT on leukocyte migration into the peritoneal
cavity induced by carrageenan in mice. Groups of mice were pre-
treated with vehicle (control group, 10 mL=kg, i.p.), dexamethasone
(Dexa) (2 mg=kg, s.c.), or CT in concentrations of 50, 100, or
200 mg=kg (i.p.) 1 hour before carrageenan (500mg per cavity,
500 mL, i.p.)-induced peritonitis. Cell counts were performed at 4
hours after the injection of carrageenan. Data are mean SEM values
(n¼ 6). Statistical significance of differences relative to the control
group were calculated by analysis of variance followed by Dunnett’s
test: *P< .01, **P< .001.
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